1. Geelhoed EA, Lewis B, Hounsome D, O’leary P. Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism. J Paediatr Child Health 2005;41:575–579.
2. Gu XF, Wang JJ, Ye J, Cheng XM. A cost-benefit evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism. Zhonghua Yu Fang Yi Xue Za Zhi 2000;34:147–149.
3. Therrell BL, Johnson A, Williams D. Status of newborn screening programs in the United States. Pediatrics 2006;117:S212–S252.
4. Xu YH, Qin YF, Zhao ZY. Retrospective study on neonatal screening for congenital hypothyroidism and phenylketomuria in China in the past 22 years. Zhonghua Er Ke Za Zhi 2009;47:18–22.
5. Mao HQ, Xu YH, Cao LP, Yang RL, Zhou XL. The relationship between the value of blood thyroid stimulating hormone on filter paper and the detection rate for congenital thyroidism. Zhejiang Yu Fang Yi Xue 2006;18:48.